Urosepsis in adults
DOI:
https://doi.org/10.2298/ABS210304015LKeywords:
urosepsis, urinary tract infections, risk factorsAbstract
Paper description:
- Urinary tract infections are a risk factor for urosepsis development, a severe complication that progresses rapidly.
- Common causes of urosepsis and information regarding the category of high-risk patients are provided.
- The increase in urinary tract infections with multiresistant bacteria is emphasized, especially in patients with recurrent urinary tract infections and their frequent treatment. These infections occur in patients with structural/functional malformations that interfere with urine flow. Urosepsis is caused by obstruction of the urinary tract; development of septic shock can often be prevented by early deopstruction.
- Early recognition of the focus of urosepsis in the urinary tract is imperative.
Abstract: Urosepsis is defined as sepsis caused by urinary tract infection (UTI). Urosepsis represents a quarter of all cases of sepsis in adults. Complications of UTIs are the most common risk factor for urosepsis development. These infections, especially pyelonephritis, often occur in patients with structural or functional malformations that interfere with normal urine flow. The problem of a significant increase in UTIs with multiresistant bacteria should be emphasized, especially in patients with recurrent UTI and their frequent treatments. As the urogenital tract is one of the most common sources of infection in sepsis in general, a detailed assessment of the tract should be carried out in all septic patients. Even though urosepsis is associated with a relatively good prognosis and lower mortality than sepsis of another etiology, it occurs rapidly and progresses at a significant speed. Since urosepsis is mainly the result of obstruction of the urinary tract, the development of septic shock can most often be prevented by implementing early deobstruction. Knowledge of the most common causes of urosepsis and the category of high-risk patients will provide clinicians with the tools with which to prevent its occurrence.
Downloads
References
Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche J, Coopersmith C, Hotchkiss R, Levy MM, Marshall J, Martin G, Opal S, Rubenfeld G, Van der Poll T, Vincent JL, Angus D. The Third International Consensus Definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801-10. https://doi.org/10.1001/jama.2016.0287
Bumbaširević V, Veličković J, Palibrk I, Jovanović B, Avramović J. Novine u dijagnostici i lečenju sepse i septičnog šoka. SJAIT. 2017;39(7-8):171-80.
Caironi P, Tognoni G, Masson S, Fumagalli R, Pesenti A, Romero M, Fanizza C, Caspani L, Faenza S, Grasselli G, Lapichino G, Antonelli M, Parrini V, Fiore G, Latini R, Gattinoni L, ALBIOS Study Investigators. Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med. 2014;370(15):1412-21. https://doi.org/10.1056/nejmoa1305727
Schmid A, Burchardi H, Clouth J, Schneider H: Burden of illness imposed by severe sepsis in Germany. Eur J Health Econ. 2002;3:77-82. https://doi.org/10.1007/s10198-002-0095-8
Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008;8:776-87. https://doi.org/10.1038/nri2402
Peach B, Garvan G, Garvan C, Cimiotti J. Risk Factors for Urosepsis in Older Adults: A Systematic Review. Gerontol Geriatr Med. 2016;2:1-7. https://doi.org/10.1177/2333721416638980
Wagenlehner FM, Lichtenstern C, Rolfes C, Mayer K, Uhle F, Weidner W, Weigand MA. Diagnosis and management for urosepsis. Int J Urol. 2013;20(10):963-70. https://doi.org/10.1111/iju.12200
Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, Vincent JL, Townsend S, Lemeshow S, Dellinger RP. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012;12(12):919-24. https://doi.org/10.1016/s1473-3099(12)70239-6
Suetens C, Hopkins S, Kolman J, Hogberg LD. Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals 2011-2012. Stockholm (Sweden): European Centre for Disease Prevention and Control; 2013.
Bonkat G, Bartolleti R, Bruyere F, Cai T, Geerlings SE, Koves B, Schubert S, Wagenlehner F. EAU guidelines on Urological infections. Edn. presented at the EAU Annual Congress Amsterdam 2020. In: EAU Guidelines [Internet]. Arnhem, The Netherlands: EAU Guidelines Office; 2020. [cited 2021 Feb 10]. Available from: http://uroweb.org/guideline/urological-infections/
Tandoğdu Z, Bartoletti R, Cai T, Çek M, Grabe M, Kulchavenya E, Koves B, Menon V, Naber K, Perepanova T, Tenke P, Wullt B, Bjerhlund Johansen TE, Wagenlehner F. Antimicrobial resistance in urosepsis: outcomes from the multinational, multicenter global prevalence of infections in urology (GPIU) study 2003-2013. World J Urol. 2016;34(8):1193-200. https://doi.org/10.1007/s00345-015-1722-1
Wagenlehner F, Tandogdu Z, Bartoletti R, Cai T, Cek M, Kulchavenya E, Koves B, Naber K, Perepanova T, Tenke P, Wullt B, Bogenhard F, Bjerklund Johansen TE. The Global Prevalence of Infections in Urology Study: A Long-Term, Worldwide Surveillance Study on Urological Infections. Pathogens. 2016;5(1):10. https://doi.org/10.3390/pathogens5010010
Dielubanza EJ, Schaeffer AJ. UTIs in women. Med Clin North Am. 2011;95(1):27-41.
Barber AE, Norton JP, Wiles TJ, Mulvey MA. Strengths and limitations of model systems for the study of UTIs and related pathologies. Microbiol Mol Biol Rev. 2016;80(2):351-67. https://doi.org/10.1128/mmbr.00067-15
Cai T, Mazzoli S, Lanzafame P, Caciagli P, Malossini G, Nesi G, Wagenlehner F, Koves B, Pickard R, Grabe M, Bjerklund Johansen TE, Bartoletti R. Asymptomatic Bacteriuria in Clinical Urological Practice: Preoperative Control of Bacteriuria and Management of Recurrent UTI. Pathogens. 2016;5(1):4. https://doi.org/10.3390/pathogens5010004
Sousa R, Muñoz-Mahamud E, Quayle J, Dias da Costa L, Casals C, Scott P, Leite P, Vilanova P, Garcia S, Ramos MH, Dias J, Soriano A, Guyot A. Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? Clin Infect Dis. 2014;59(1):41-7. https://doi.org/10.1093/cid/ciu235
Soltanzadeh M, Ebadi A. Is presence of bacteria in preoperative microscopic urinalysis of the patients scheduled for cardiac surgery a reason for cancellation of elective operation? Anesthesiol Pain Med. 2013;2:174-7. https://doi.org/10.5812/aapm.8667
Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003;348:138-50.
Van Amersfoort ES, Van Berkel TJ, Kuiper J. Receptors, mediators, and mechanisms involved in bacterial sepsis andseptic shock. Clin Microbiol Rev. 2003;16:379-414. https://doi.org/10.1128/cmr.16.3.379-414.2003
Heppner HJ, Yapan F, Wiedemann A. Urosepsis in geriatric patients. Aktuelle Urol. 2016;47(1):54-9. https://doi.org/10.1055/s-0041-106184
Wagenlehner FM, Pilatz A, Weidner W, Naber KG. Urosepsis: overview of the diagnostic and treatment challenges. Microbiol Spectr. 2015;3(5):UTI-0003-2021. https://doi.org/10.1128/microbiolspec.uti-0003-2012
Kehinde EO, Rotimi VO, Al-Hunayan A, Abdul-Halim H, Boland F, Al-Awadi KA. Bacteriology of urinary tract infection associated with indwelling J ureteral stents. J Endourol. 2004;18(9):891-6. https://doi.org/10.1089/end.2004.18.891
Lange D, Bidnur S, Hoag N, Chew BH. Ureteral stent-associated complications - where we are and where we are going. Nat Rev Urol. 2015;12(1):17-25. https://doi.org/10.1038/nrurol.2014.340
Blackmur JP, Maitra NU, Marri RR, Housami F, Malki M, McIlhenny C. Analysis of factors’ association with risk of postoperative urosepsis in patients undergoing ureteroscopy for treatment of stone disease. J Endourol. 2016;30(9):963-9. https://doi.org/10.1089/end.2016.0300
Tandogdu Z, Bjerklund Johansen TE, Bartoletti R, Wagenlehner F. Management of the Urologic Sepsis Syndrome. Eur Urol Suppl. 2016;15(4):102-11. https://doi.org/10.1016/j.eursup.2016.04.004
Sohn DW, Kim SW, Hong CG, Yoon BI, Ha US, Cho YH. Risk factors of infectious complication after ureteroscopic procedures of the upper urinary tract. J Infect Chemother. 2013;19(6):1102-8. https://doi.org/10.1007/s10156-013-0632-7
Mitsuzuka K, Nakano O, Takahashi N, Satoh M. Identification of factors associated with postoperative febrile urinary tract infection after ureteroscopy for urinary stones. Urolithiasis. 2016;44(3):257-62. https://doi.org/10.1007/s00240-015-0816-y
Scotland KB, Lange D. Prevention and management of urosepsis triggered by ureteroscopy. Res Rep Urol. 2018;10:43-9.
Gupta M, Ost M, Shah B, Mc Dougal EM, Smith A. Percutaneous management of upper urinary tract. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders; 2007. p. 1526-63. https://doi.org/10.1111/j.1749-771x.2007.00017.x
Nikić P, Durutović O, Kajmaković B, Nale D, Bumbaširević U, Radovanović M, Milenković Petronić D, Džamić Z. Complications associated with percutaneous nephrolitholapaxy (PCNL) - our experience and literature review. Acta Chir Iugosl. 2014;61:51-6. https://doi.org/10.2298/aci1401051n
Bansal SS, Pawar PW, Sawant AS, Tamhankar AS, Patil SR, Kasat GV. Predictive factors for fever and sepsis following percutaneous nephrolithotomy: A review of 580 patients. Urol Ann. 2017;9(3):230-3. https://doi.org/10.4103/ua.ua_166_16
Liu YQ, Lu J, Hao YC, Xiao CL, Ma LL. Predicting model based on risk factors for urosepsis after percutaneous nephrolithotomy. Beijing Da XueXueBao Yi Xue Ban. 2018;50(3):507-13. https://doi.org/10.1016/j.juro.2018.02.365
Likic I, Kadija S, Ladjevic N, Stefanovic A, Jeremic K, Petkovic S, Dzamic Z. Analysis of urologic complications after radical hysterectomy. Am J Obstet Gynecol 2008;199(6):644-5. https://doi.org/10.1016/j.ajog.2008.06.034
Kalra OP, Raizada A. Approach to a Patient with Urosepsis. J Glob Infect Dis. 2009;1(1):57-63.
Mimic A, Bantel C, Jovicic J, Mimic B, Kisic-Tepavcevic D, Durutovic O, Ladjevic N. Psychological factors as predictors of early postoperative pain after open nephrectomy. Journal of Pain Research 2018;11:955-66. https://doi.org/10.2147/jpr.s152282
Stamenkovic D, Laycock H, Karanikolas M, Ladjevic N, Neskovic V, Bantel C. Chronic Pain and Chronic Opioid Use After Intensive Care Discharge - Is It Time to Change Practice? Frontiers in Pharmacology 2019;10:23. https://doi.org/10.3389/fphar.2019.00023
Qiang XH, Yu TO, Li JN, Zhou LX. Prognosis Risk of Urosepsis in Critical Care Medicine: A Prospective Observational Study. Biomed Res Int. 2016;2016:9028924. https://doi.org/10.1155/2016/9028924
Yamamichi F, Shigemura K, Kitagawa K, Takaba K, Tokimatsu I, Arakawa S, Fujisawa M. Shock due to urosepsis: A multicentre study. Can Urol Assoc J. 2017;11(3-4):E105-9. https://doi.org/10.5489/cuaj.4097
Mariappan P, Loong CW. Midstream urine culture and sensitivity test is a poor predictor of infected urine proximal to the obstructing ureteral stone or infected stones: a prospective clinical study. J Urol. 2004;171(6 Pt 1):2142-5. https://doi.org/10.1097/01.ju.0000125116.62631.d2
Eswara JR, Shariftabrizi A, Sacco D. Positive stone culture is associated with a higher rate of sepsis after endourological procedures. Urolithiasis. 2013;41(5):411-4. https://doi.org/10.1007/s00240-013-0588-1
Schuetz P, Christ-Crain M, Thomann R, Falconnier C, Wolbers M, Widmer I, Neidert S, Fricker T, Blum C, Schild U, Regez K, Schoenenberger R, Henzen C, Bregenzer T, Hoess C, Krause M, Bucher H, Zimmerli W, Mueller B, ProHOSP Study Group. Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial. JAMA. 2009;302(10):1059-66. https://doi.org/10.1001/jama.2009.1297
Nobre V, Harbarth S, Graf JD, Rohner P, Pugin J. Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med. 2008;177:498-505. https://doi.org/10.1164/rccm.200708-1238oc
Zheng J, Li Q, Fu W, Ren J, Song S, Deng G, Yao J, Wang Y, Li W, Yan J. Procalcitonin as an early diagnostic and monitoring tool in urosepsis following percutaneous nephrolithotomy. Urolithiasis. 2015;43(1):41-7. https://doi.org/10.1007/s00240-014-0716-6
Fukunaga A, Nishihara T, Kono Y, Matsumoto K, Matsuoka T, Sugino Y, Okada T, Kawakita M. Risk Factors for Mortality in Patients with Urosepsis. Hinyokika Kiyo. 2017;63(5):195-9.
Review M, Agilli M, Sener I, Yesildal F, Honca T, Aydin I, Akgul EO, Yaman H. A new marker for the diagnosis of sepsis: Presepsin. J Investig Biochem. 2012;1(1):55-7. https://doi.org/10.5455/jib.20120521073837
Vincent JL, Ferguson A, Pickkers P, Jakob SM, Jaschinski U, Almekhlafi GA, Leone M, Mokhtari M, Fontes LE, Bauer PR, Sakr Y; Ladjevic N at ICON Investigators. The clinical relevance of oliguria in the critically ill patient: analysis of a large observational database. Critical Care 2020;24:171. https://doi.org/10.1186/s13054-020-02858-x
Acheampong A, Vincent JL. A positive fluid balance is an independent prognostic factor in patients with sepsis. Crit Care 2015;19(1):251. https://doi.org/10.1186/s13054-015-0970-1
Sakr Y, Rubatto Birri PN, Kotfis K, Nanchal R, Shah B, Kluge S, Schroeder ME, Marshall JC, Vincent JL, Intensive Care Over Nations Investigators. Higher Fluid Balance Increases the Risk of Death from Sepsis: Results from a Large International Audit. Crit Care Med. 2017;45(3):386-94. https://doi.org/10.1097/ccm.0000000000002189
Ferrer R, Martin-Loeches I, Phillips G. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749-55. https://doi.org/10.1097/ccm.0000000000000330
Karam G, Chastre J, Wilcox MH, Vincent JL. Antibiotic strategies in the era of multidrug resistance. Crit Care. 2016;20(1):136. https://doi.org/10.1186/s13054-016-1320-7
Pletz MW, Weis S, Forstner C, Wagenlehner F. Urosepsis. Med Klin Intensiv med Notfmed. 2018;113(2):143-56. https://doi.org/10.1007/s00063-018-0406-1
Bader MS, Loeb M, Brooks AA. An update on the management of UTIs in the era of antimicrobial resistance. Postgrad Med. 2017;129(2):242-58.
Jokar A, Ahmadi K, Taherinia A, Didgar F, Kazemi F, Bahramian M. The effects of injected Vitamin D on prognosis of patients with urosepsis. Horm Metab Res. 2018;50(5):383-8. https://doi.org/10.1055/a-0595-7731
Gvozdić B, Milenković Petronić D, Ladjevic N, Vuksanović A, Durutović O. The examination of the quality-of-life changes of patients with urolithiasis regarding different methods of treatment. Vojnosanit Pregl. 2020;77(2):158-64. https://doi.org/10.2298/vsp180309060g
Chew BH, Flannigan R, Kurtz M, Gershman B, Arsovska O, Paterson R, Eisner B, Lange D. A single dose of intraoperative antibiotics is sufficient to prevent urinary tract infection during ureteroscopy. J Endourol. 2016;30(1):63-8. https://doi.org/10.1089/end.2015.0511
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Archives of Biological Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Authors grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution 4.0 International License that allows others to share the work with an acknowledgment of the work’s authorship and initial publication in this journal.